Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Original Articles: Gastrointestinal"'
Autor:
Panagiotis Sarantis, Maria Michelli, Dimitrios Schizas, Michalis V. Karamouzis, Stamatios Theoharis, Georgia Kyriakopoulou, Athanasios G. Papavassiliou, Ioanna Giannopoulou, Ilenia Chatziandreou, Evangelos Koustas, Angelica A. Saetta
Publikováno v:
American Journal of Clinical Oncology
Supplemental Digital Content is available in the text.
Objectives: Autophagy plays a dual role in tumorigenesis. In the initial stages, it promotes cell survival and suppresses carcinogenesis, whereas in cancer development, it induces cancer cel
Objectives: Autophagy plays a dual role in tumorigenesis. In the initial stages, it promotes cell survival and suppresses carcinogenesis, whereas in cancer development, it induces cancer cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74413d74aeba05a7aae44666063c552
http://europepmc.org/articles/PMC6766360
http://europepmc.org/articles/PMC6766360
Autor:
Stuti Shroff, Major K. Lee, James M. Metz, Edgar Ben-Josef, Ursina R. Teitelbaum, Kim A. Reiss, William Tristram Arscott, Kevin T. Nead, Mark H. O'Hara, John N. Lukens, Andrzej P. Wojcieszynski, Jacob E. Shabason, Jeffrey A. Drebin, Sriram Venigalla, Adham S. Bear, John P. Plastaras, Arturo Loaiza-Bonilla
Publikováno v:
American Journal of Clinical Oncology
Purpose: This study evaluates the toxicity and tumor response with concurrent nab-paclitaxel chemoradiotherapy (CRT) compared with standard (5-fluorouracil or gemcitabine) CRT. Materials and Methods: Fifty patients with borderline resectable or unres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e8550b9eef23f792c2aefeb1fcf0f3
https://pubmed.ncbi.nlm.nih.gov/34310350
https://pubmed.ncbi.nlm.nih.gov/34310350
Autor:
Xiaodong Li, Yong Liu, T. Zhang, Guoqi Zhao, Shengyu Yao, Ye Hu, Wenzhi Tu, Zhekai Hu, Xuming Chen, Ying Chen, Ge Yan, Tingfeng Chen, Z. Chen, Yi Xu, Hui Chen, Xia He
Publikováno v:
American Journal of Clinical Oncology
The Intergroup 0116 study has demonstrated a significant survival benefit for completely resected (R0) gastric cancer patients treated with a fluorouracil/leucovorin chemoradiotherapy regimen. However, this regimen is also toxic and less effective in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf7c4b171e9729a6e468c6994fd7eeb
https://doi.org/10.1097/coc.0000000000000373
https://doi.org/10.1097/coc.0000000000000373
Autor:
Brian McMillen, Jon A. Steingrimsson, Tracey J. McDuffie, Joshua M McHale, Victor E. Pricolo, Mark Shparber
Publikováno v:
American Journal of Clinical Oncology
Objectives: National Comprehensive Cancer Network (NCCN) guidelines for stage III colon cancer define low-risk versus high-risk patients based on T (1 to 3 vs. 4) and N (1 vs. 2) status, with some variations in treatment. This study analyzes the impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183e66fb938a6bd37bb4127f42390a8b
https://pubmed.ncbi.nlm.nih.gov/31764018
https://pubmed.ncbi.nlm.nih.gov/31764018
Autor:
Hyungwoo Cho, Kyu-Pyo Kim, Hong Seok Jang, Jeong Eun Kim, Jong Hoon Kim, Myung Ah Lee, Tae-Won Kim, Dae Yong Kim, Yong Sang Hong, Jin Cheon Kim, Jae Hwan Oh, Sun-Young Kim, Seong Taek Oh, Chang Sik Yu
Publikováno v:
American Journal of Clinical Oncology
Supplemental Digital Content is available in the text.
Objectives: Controversy surrounds the management of patients with locally advanced rectal cancer with synchronous resectable liver metastases (LMs). This study was designed to improve both s
Objectives: Controversy surrounds the management of patients with locally advanced rectal cancer with synchronous resectable liver metastases (LMs). This study was designed to improve both s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03421a392c2cbb5f5c1118c981b831ea
http://europepmc.org/articles/PMC5120770
http://europepmc.org/articles/PMC5120770
Autor:
Burtness, Barbara, Powell, Mark, Catalano, Paul, Berlin, Jordan, Liles, Darla K., Chapman, Andrew E., Mitchell, Edith, Benson, Al B.
Publikováno v:
American Journal of Clinical Oncology
Objectives: The primary objective was to determine the response rate in patients with metastatic pancreatic cancer treated in first line with irinotecan/docetaxel combination (Arm A) or with irinotecan/docetaxel/cetuximab combination (Arm B). Seconda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::962ffd9054ca2c16c9b7f99f4c661668
http://europepmc.org/articles/PMC4177955
http://europepmc.org/articles/PMC4177955
Autor:
Kikuchi, Luciana, Oliveira, Claudia P., Alvares-da-Silva, Mario R., Tani, Claudia M., Diniz, Marcio A., Stefano, Jose T., Chagas, Aline L., Alencar, Regiane S.S.M., Vezozzo, Denise C.P., Santos, Gilmar R., Campos, Priscila B., Alves, Venancio AF., Ratziu, Vlad, Carrilho, Flair J.
Publikováno v:
American Journal of Clinical Oncology
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) has emerged as an important cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). The Barcelona Clinic Liver Cancer (BCLC) system is the preferred staging system to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db49e830a843dac34bcb07f7f7164674
http://europepmc.org/articles/PMC5049973
http://europepmc.org/articles/PMC5049973